Clinical Trials › NCT06566261
Active, Not RecruitingPhase 1
ABA-101 in Participants With Progressive Multiple Sclerosis
Sponsored by Abata Therapeutics
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 12
Target enrollment
3
U.S. states
Sep 2024
Start date
Feb 2027
Expected completion
Interventions / Treatments
ABA-101
Conditions studied
Progressive Multiple Sclerosis
Where this trial is running (3 sites)
Participating MS centers on MS Buddy (3)
Robert Wood Johnson Center for MS
New Brunswick, NJ
New Brunswick, NJ
Johns Hopkins Multiple Sclerosis Center
Baltimore, MD
Baltimore, MD
Mellen Center for MS Treatment & Research
Cleveland, OH
Cleveland, OH
MS centers in Maryland
Compare treatment centers near a trial site by center type, providers and trials.
View Maryland centersMore Phase 1 trials
Browse all Phase 1 MS trialsThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.